Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials-Reference-Cited by-同舟云学术

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

Published:2012-08 Issue:8 Volume:13 Page:827-837
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Tran Hai T,Liu Yuan,Zurita Amado J,Lin Ying,Baker-Neblett Katherine L,Martin Anne-Marie,Figlin Robert A,Hutson Thomas E,Sternberg Cora N,Amado Rafael G,Pandite Lini N,Heymach John V

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Mutations of the VHL tumour suppressor gene in renal carcinoma;Gnarra;Nat Genet,1994

2. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas;Na;J Urol,2003

3. Targeting HIF-1 for cancer therapy;Semenza;Nat Rev Cancer,2003

4. Expression of vascular endothelial growth factor protein in human renal cell carcinoma;Jacobsen;BJU Int,2004

5. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study;Cancer Reports;2024-06

2. A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer;JNCI Cancer Spectrum;2024-04-30

3. Osteopontin in cancer;Advances in Clinical Chemistry;2024

4. Biomarkers in Renal Cell Carcinoma;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

5. Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma;Cancer Drug Resistance;2023-12-28